Currently out of the existing stock ratings of Caitlin Cronin, 35 are a BUY (67.31%), 17 are a HOLD (32.69%).

Caitlin Cronin

Work Performance Price Targets & Ratings Chart

Analyst Caitlin Cronin, currently employed at CANACCORD, carries an average stock price target met ratio of 56.42% that have a potential upside of 31.32% achieved within 97 days.

Caitlin Cronin’s has documented 103 price targets and ratings displayed on 10 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on BVS, Bioventus at 16-Jun-2026.

Wall Street Analyst Caitlin Cronin

Analyst best performing recommendations are on KRMD (REPRO MED SYSTEMS).
The best stock recommendation documented was for SNN (SMITH & NEPHEW SNATS) at 5/11/2026. The price target of $30 was fulfilled within 1 day with a profit of $0.9 (3.09%) receiving and performance score of 30.93.

Average potential price target upside

of $13.26 (25.72%) on ESTA (ESTABLISHMENT LABS HOLDINGS).
of $9.19 (19.47%) on VCEL (VERICEL CORP ORD).
of $6.26 (38.71%) on AXGN (AXOGEN).

ATEC Alphatec Holdings AXGN Axogen BVS Bioventus ENOV Enovis Corp ESTA Establishment Labs Holdings GMED Globus Medical INMD InMode Ltd KRMD Repro Med Systems SNN Smith & Nephew SNATS VCEL Vericel Corp Ord

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Vik Chopra (BMO)